Relación entre el uso de glucocorticoides y el daño crónico en Lupus Eritematoso Sistémico: una asociación precoz y nociva. Estudio exploratorio

Danza, Alvaro; Narváez, Jorge; Graña, Diego; Pérez, Leticia; Viera, Alexander; Baccelli, Augusto; Borgia, Ignacio; Roca, Federico.
Rev. Urug. med. Interna ; 6(1): 14-23, mar. 2021. tab, graf
Artigo em Espanhol | LILACS-Express | ID: biblio-1155637

Documentos relacionados

  1. Nefritis lúpica: experiencia con dosis reducidas de glucocorticoides en una unidad de enfermedades autoinmunes sistémicas
  2. Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study.
  3. [Pure red cell aplasia in children: a clinical analysis of 16 cases].
  4. Dexamethasone Compared to Prednisone for the Treatment of Children With Acute Asthma Exacerbations.
  5. Clinical effect of different prednisone regimens in the treatment of children with primary nephrotic syndrome and risk factors for recurrence.
  6. Urinary glucocorticoids in harbour seal (Phoca vitulina) pups during rehabilitation.
  7. [A cross-sectional study on application of glucocorticoid in systemic lupus erythematosus patients].
  8. Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goal.
  9. Visual outcome of various dose of glucocorticoids treatment in nonarteritic anterior ischemic optic neuropathy- a retrospective analysis.
  10. [Clinical assessment of moderate-dose glucocorticoid in the treatment of recurrence of primary nephrotic syndrome in children: a prospective randomized controlled trial].